Table 4.
Variable | Patients n (%) + |
RNA Detection Rate n (%) ++ |
p Value (χ² or Fisher Test) |
---|---|---|---|
Genders | |||
Female | 209 (44.5) | 52 (24.9) | 0.218 |
Male | 260 (55.4) | 78 (30.0) | |
Age groups | |||
≤5 | 90 (19.2) | 20 (22.2) | 0.434 |
6–15 | 187 (39.9) | 55 (29.4) | |
16–45 | 133 (28.4) | 41 (30.8) | |
≥46 | 59 (12.6) | 14 (23.7) | |
Regions | |||
North | 66 (14.1) | 13 (19.7) | 0.116 |
South | 403 (85.9) | 117 (29) | |
Year of illness * | |||
2017 | 149 (31.8) | 42 (28.2) | 0.116 |
2018 | 179 (38.2) | 41 (22.9) | |
2019 | 141 (44.6) | 47 (33.3) | |
Clinical diagnoses ** | |||
Non-specific febrile illness | 131 (27.9) | 33 (25.2) | 0.905 |
Suspected Dengue | 27 (5.8) | 9 (33.3) | |
Dengue without warning sign | 292 (62.3) | 82 (28.1) | |
Dengue with warning sign | 9 (1.9) | 3 (33.3) | |
Severe Dengue | 10 (2.1) | 3 (30) | |
Overall | 469 (100) | 130 (27.7) |
+ % in total for each variable. ++ % in each lane. * Age groups were defined based on the date and year of illness. ** Clinical diagnoses identified on patient’s initial hospital visit.